Showing 1 - 7 results of 7 for search 'Changxian Li', query time: 0.03s
Refine Results
-
1
An Ultra-Wideband MIMO Bowl-Shaped Monopole Antenna with Sturdy and Simple Construction by Changxian Li, Pin Wen, Xiujuan Lin, Di Wu, Changfei Zhou
Published 2023-01-01
Article -
2
-
3
ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma by Shuochen Liu, Shilong Fan, Yirui Wang, Ruixiang Chen, Ziyi Wang, Yaodong Zhang, Wangjie Jiang, Yananlan Chen, Xiao Xu, Yue Yu, Changxian Li, Xiangcheng Li
Published 2023-05-01
Article -
4
RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma by Jiang Chang, Yaodong Zhang, Tao Zhou, Qian Qiao, Jijun Shan, Yananlan Chen, Wangjie Jiang, Yirui Wang, Shuochen Liu, Yuming Wang, Yue Yu, Changxian Li, Xiangcheng Li
Published 2024-04-01
Article -
5
Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation by Yananlan Chen, Xiao Xu, Yirui Wang, Yaodong Zhang, Tao Zhou, Wangjie Jiang, Ziyi Wang, Jiang Chang, Shuochen Liu, Ruixiang Chen, Jijun Shan, Jifei Wang, Yuming Wang, Changxian Li, Xiangcheng Li
Published 2023-10-01
Article -
6
CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinoma by Shuochen Liu, Yirui Wang, Tianlin Wang, Kuangheng Shi, Shilong Fan, Chang Li, Ruixiang Chen, Jifei Wang, Wangjie Jiang, Yaodong Zhang, Yananlan Chen, Xiao Xu, Yue Yu, Changxian Li, Xiangcheng Li
Published 2024-02-01
Article -
7
Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial by Jian Wang, Hao Wu, Jing Sun, Xiao Li, Yongqian Shu, Xiaofeng Wu, Guoqiang Wang, Huajun Li, Xiaofeng Chen, Yanhong Gu, Yang Shao, Qianwen Shao, Feipeng Zhu, Xiaofeng Qian, Jun Hu, Fengjiao Zhao, Weidong Mao, Gaohua Han, Changxian Li, Yongxiang Xia, Poshita Kumari Seesaha, Dongqin Zhu, Junling Zhang, Xuehao Wang, Xiangcheng Li
Published 2020-10-01
Article